Back
Can Fite Biofarma Vs. TransMedics Group Industry Stock Comparison
Sell
42
CANF
Can Fite Biofarma
Last Price:
2.02
Seasonality Move:
0.68%
Buy
65
TMDX
TransMedics Group
Last Price:
159.11
Seasonality Move:
12.72%
Sell
42
Can Fite Biofarma (CANF)
is a Sell
Is Can Fite Biofarma a Buy, Sell or Hold?
- The current Can Fite Biofarma [CANF] share price is $2.02. The Score for CANF is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
- CANF is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
65
TransMedics Group (TMDX)
is a Buy
Is TransMedics Group a Buy, Sell or Hold?
- The current TransMedics Group [TMDX] share price is $159.14. The Score for TMDX is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.
- TMDX is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
CANF Stock Price Chart
What is Can Fite Biofarma's stock price today?
-
The Can Fite Biofarma share price today is $2.02
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CANF is experiencing slight buying pressure.
TMDX Stock Price Chart
What is TransMedics Group's stock price today?
-
The TransMedics Group share price today is $159.14
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TMDX is experiencing buying pressure, which is a positive indicator for future bullish movement.
CANF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.14 | Sell |
| Relative Strength Index (14 RSI): | 36.28 | Sell |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.08 - 2.36) | Sell |
| Bollinger Bands (100): | (2.11 - 3.15) | Sell |
TMDX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.65 | Sell |
| Relative Strength Index (14 RSI): | 53.07 | Buy |
| Chaikin Money Flow: | 1647554 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (144.71 - 167.33) | Buy |
| Bollinger Bands (100): | (136.45 - 160.09) | Buy |
CANF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.04 | Sell |
| 20-day SMA: | 2.2 | Sell |
| 50-day SMA: | 2.59 | Sell |
| 200-day SMA: | 2.36 | Sell |
| 8-day EMA: | 2.07 | Sell |
| 20-day EMA: | 2.19 | Sell |
| 50-day EMA: | 2.41 | Sell |
| 200-day EMA: | 2.56 | Sell |
TMDX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 156.82 | Buy |
| 20-day SMA: | 152.14 | Buy |
| 50-day SMA: | 155.84 | Buy |
| 200-day SMA: | 116.53 | Buy |
| 8-day EMA: | 154.32 | Buy |
| 20-day EMA: | 154.91 | Buy |
| 50-day EMA: | 153.28 | Buy |
| 200-day EMA: | 123.8 | Buy |
Can Fite Biofarma Earnings Growth & CANF Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.38 per share, and an increase next year of $0.04 per share.
TransMedics Group Earnings Growth & TMDX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.45 per share, an increase next quarter of $0.19 per share, an increase this year of $1.86 per share, and an increase next year of $0.61 per share.
Can Fite Biofarma Technical Analysis
| Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | 27 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
TransMedics Group Technical Analysis
| Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | 27 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||